Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dengue DNA vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics

Drug Profile

Dengue DNA vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics

Alternative Names: D1ME; Tetravalent dengue plasmid DNA vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics; Tetravalent dengue vaccine - Naval Medical Research Center/Fresh Tracks Therapeutics; TVDV

Latest Information Update: 25 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Naval Medical Research Center; Vical
  • Developer Fresh Tracks Therapeutics; Naval Medical Research Center; United States Army Medical Research and Materiel Command; Walter Reed Army Institute of Research
  • Class Dengue vaccines; Gene therapies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Dengue

Most Recent Events

  • 19 Sep 2023 Discontinued - Phase-I for Dengue (Prevention) in USA (IM)
  • 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
  • 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top